ArticleUrolithiasis2025
Flexible ureteroscopy under local anesthesia for 2-4 cm renal stones: FANS outperforms traditional sheaths.
Article in Urolithiasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate the efficacy and safety of a Flexible and Navigable Suction Ureteral Access Sheath (FANS) in flexible ureteroscopic lithotripsy (FURL) under local anesthesia for renal stones 2-4 cm. We retrospectively analyzed clinical data from patients with renal stones 2-4 cm who underwent local anesthesia FURL from January 2023 to December 2024. Patients were divided into two groups based on the type of sheath used: FANS or traditional ureter access sheath (T-UAS) group. Demographic data and perioperative indicators were compared. A total of 372 patients were included in the study, with 187 in the FANS and 185 in the T-UAS group. FANS achieved an 78.6% one-time stone-free rate (SFR) (vs. 57.8% in T-UAS, P < 0.001), with significantly lower postoperative fever (2.1% vs. 8.1%) and steinstrasse (1.1% vs. 5.9%). FANS enhances FURL efficacy for 2-4 cm renal stones under local anesthesia, provides an alternative to percutaneous nephrolithotomy (PCNL) for select patients.
Indexed as
Identifiers
41428095What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.